These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 16289766)

  • 41. Immune responses of a liposome/ISCOM vaccine adjuvant against streptococcal fibronectin binding protein 1 (Sfb1) in mice.
    McArthur J; Schulze K; Chin J; Currie BJ; Sriprakash KS; Talay SR; Chhatwal GS; Guzmán CA; Walker MJ
    Indian J Med Res; 2004 May; 119 Suppl():115-20. PubMed ID: 15232175
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Bivalent mucosal peptide vaccines administered using the LCP carrier system stimulate protective immune responses against Streptococcus pyogenes infection.
    Schulze K; Ebensen T; Chandrudu S; Skwarczynski M; Toth I; Olive C; Guzman CA
    Nanomedicine; 2017 Nov; 13(8):2463-2474. PubMed ID: 28887213
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Identification of the domains of the fibronectin-binding protein I of Streptococcus pyogenes responsible for adjuvanticity.
    Schulze K; Guzmán CA
    FEMS Immunol Med Microbiol; 2003 Jul; 37(2-3):173-7. PubMed ID: 12832122
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Vaccination with Streptococcus pyogenes nuclease A stimulates a high antibody response but no protective immunity in a mouse model of infection.
    Radcliff FJ; Fraser JD; Proft T
    Med Microbiol Immunol; 2015 Apr; 204(2):185-91. PubMed ID: 25119670
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Immune response to superoxide dismutase in group A streptococcal infection.
    McMillan DJ; Davies MR; Good MF; Sriprakash KS
    FEMS Immunol Med Microbiol; 2004 Apr; 40(3):249-56. PubMed ID: 15039102
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Vaccination with formalin-inactivated influenza vaccine protects mice against lethal influenza Streptococcus pyogenes superinfection.
    Okamoto S; Kawabata S; Fujitaka H; Uehira T; Okuno Y; Hamada S
    Vaccine; 2004 Jul; 22(21-22):2887-93. PubMed ID: 15246625
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Mucosal vaccination with a multicomponent adenovirus-vectored vaccine protects against Streptococcus pneumoniae infection in the lung.
    Arévalo MT; Xu Q; Paton JC; Hollingshead SK; Pichichero ME; Briles DE; Girgis N; Zeng M
    FEMS Immunol Med Microbiol; 2009 Apr; 55(3):346-51. PubMed ID: 19291171
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Structure-activity relationship for the development of a self-adjuvanting mucosally active lipopeptide vaccine against Streptococcus pyogenes.
    Zaman M; Abdel-Aal AB; Fujita Y; Ziora ZM; Batzloff MR; Good MF; Toth I
    J Med Chem; 2012 Oct; 55(19):8515-23. PubMed ID: 22974133
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Vaccination with Streptococcus suis serotype 2 recombinant 6PGD protein provides protection against S. suis infection in swine.
    Tan C; Liu M; Liu J; Yuan F; Fu S; Liu Y; Jin M; Bei W; Chen H
    FEMS Microbiol Lett; 2009 Jul; 296(1):78-83. PubMed ID: 19459970
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Lethal shock induced by streptococcal pyrogenic exotoxin A in mice transgenic for human leukocyte antigen-DQ8 and human CD4 receptors: implications for development of vaccines and therapeutics.
    Welcher BC; Carra JH; DaSilva L; Hanson J; David CS; Aman MJ; Bavari S
    J Infect Dis; 2002 Aug; 186(4):501-10. PubMed ID: 12195377
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Combinatorial Synthetic Peptide Vaccine Strategy Protects against Hypervirulent CovR/S Mutant Streptococci.
    Pandey M; Mortensen R; Calcutt A; Powell J; Batzloff MR; Dietrich J; Good MF
    J Immunol; 2016 Apr; 196(8):3364-74. PubMed ID: 26969753
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Identification of new candidate vaccine antigens made by Streptococcus pyogenes: purification and characterization of 16 putative extracellular lipoproteins.
    Lei B; Liu M; Chesney GL; Musser JM
    J Infect Dis; 2004 Jan; 189(1):79-89. PubMed ID: 14702157
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Protection against group A streptococcal infection by vaccination with self-adjuvanting lipid core M protein peptides.
    Olive C; Hsien K; Horváth A; Clair T; Yarwood P; Toth I; Good MF
    Vaccine; 2005 Mar; 23(17-18):2298-303. PubMed ID: 15755615
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Immunization with C5a peptidase from either group A or B streptococci enhances clearance of group A streptococci from intranasally infected mice.
    Cleary PP; Matsuka YV; Huynh T; Lam H; Olmsted SB
    Vaccine; 2004 Oct; 22(31-32):4332-41. PubMed ID: 15474726
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Protective immunization in mice against group B streptococci using encapsulated C5a peptidase.
    Santillan DA; Andracki ME; Hunter SK
    Am J Obstet Gynecol; 2008 Jan; 198(1):114.e1-6. PubMed ID: 17905172
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Analysis of the coverage capacity of the StreptInCor candidate vaccine against Streptococcus pyogenes.
    De Amicis KM; Freschi de Barros S; Alencar RE; Postól E; Martins Cde O; Arcuri HA; Goulart C; Kalil J; Guilherme L
    Vaccine; 2014 Jul; 32(32):4104-10. PubMed ID: 23994376
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Evaluation of the immunogenicity and the protective efficacy of a novel identified immunogenic protein, SsPepO, of Streptococcus suis serotype 2.
    Li J; Xia J; Tan C; Zhou Y; Wang Y; Zheng C; Chen H; Bei W
    Vaccine; 2011 Sep; 29(38):6514-9. PubMed ID: 21767591
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Structural optimisation of a conformational epitope improves antigenicity when expressed as a recombinant fusion protein.
    Georgousakis MM; Hofmann A; Batzloff MR; McMillan DJ; Sriprakash KS
    Vaccine; 2009 Nov; 27(48):6799-806. PubMed ID: 19729086
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Induction of cross-protective immunity against influenza A virus H5N1 by an intranasal vaccine with extracts of mushroom mycelia.
    Ichinohe T; Ainai A; Nakamura T; Akiyama Y; Maeyama J; Odagiri T; Tashiro M; Takahashi H; Sawa H; Tamura S; Chiba J; Kurata T; Sata T; Hasegawa H
    J Med Virol; 2010 Jan; 82(1):128-37. PubMed ID: 19950232
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Microencapsulation of Streptococcus equi antigens in biodegradable microspheres and preliminary immunisation studies.
    Azevedo AF; Galhardas J; Cunha A; Cruz P; Gonçalves LM; Almeida AJ
    Eur J Pharm Biopharm; 2006 Oct; 64(2):131-7. PubMed ID: 16846728
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.